Login

COAL of Africa CEO Discusses Government Developments | John Wallington - CEO of Coal of Africa Ltd 00:10:00

Share On Facebook Share On Twitter

john wallington is the ceo of coal of africa ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Mastering Digital & Pharma Investments: Insights from Meeta Shetty of Tata Asset Management | Meeta Shetty - Fund Manager, Tata Asset Management
00:00:00
Moritz F. Jäger,CTO of Northern Bitcoin
00:10:00
District Center's Smart Building Platform Transforms Workplace with Advanced Technology
00:10:00
FPX Nickel Advances Massive Baptiste Deposit in British Columbia
00:10:00
Urs Jordi to Continue as CEO of Aryzta Until 2024: A Turnaround Success Story | Urs Jordi, CEO, Aryzta Inc.
00:10:00
Introducing Bernard Wealth Management: Expertise and Personalized Service| Adam Schwallier, President, Schwallier Wealth Management LLC.
00:00:00
Stephen Kopecky, M.D. Cardiologist, Mayo Clinic / Ask Mayo Clinic: Coronary Artery Disease
00:10:00
Questioning the Manager: Exploring Investment Opportunities with James Henderson
00:10:00
Introduction to Schwallier Wealth Management with Adam Schwallier 3 | Adam Schwallier, President, Schwallier Wealth Management LLC.
00:10:00
UOB's Quality Growth Strategy: Antony Creighton and Dharmo Soejanto Discuss Key Drivers for Sustainable Returns | Dharmo Soejanto - Antony Creighton
00:10:00
William "Bill" Nuti, CEO of NCR Corp., discusses the company's third-quarter performance.|Michael D. Hayford Retiring as NCR Chief Executive Officer
00:10:00
"Navigating Market Volatility: Javid Mirza's Insights on Economic Challenges and Portfolio Strategies at Canaccord Genuity"

© 2017 - Neuhu+